Cellmid 2018 Annual Report

24

DIRECTORS’

REPORT

CONTINUED

Directors’ and KMP option holdings

The number of options held in the company during the ﬁnancial year by each director and member of key management

personnel of Cellmid Limited, including their personally related parties, are set out below.

^ Dennis Eck is expected to be remunerated on an equity basis, subject to shareholders’ approval at the next Annual General

Meeting of the Group. In the event that shareholders’ approval is not received he will receive the equivalent remuneration to

other non-executive directors in cash.

Relationship between remuneration policy and company performance

The proportion of remuneration linked to performance and the proportion that is ﬁxed is as follows:

2018 2017 2018 2017 2018 2017

% % % % % %

Directors

David King 100.00 100.00 - - - -

Maria Halasz 100.00 100.00 - - - -

Bruce Gordon 100.00 100.00 - - - -

Fintan Walton 100.00 100.00 - - - -

Martin Cross 100.00 - - - - -

Dennis Eck^ - - - - - -

Fixed remuneration At risk STI At risk LTI

* On 23 November 2017, the Group completed a twenty to one share consolidation

Balance at Disposed/ Received as Balance at Vested and

beginning of Expired/ part of 2017 end of exercisable at

year Acquired Exercised/ remuneration Consolidation year end of year

2017

David King 15,250,000 - (11,250,000) - - 4,000,000 4,000,000

Maria Halasz 6,500,000 - (6,500,000) - - - -

Bruce Gordon 2,000,000 1,000,000 (1,000,000) - - 2,000,000 2,000,000

Fintan Walton 2,000,000 250,000 (250,000) - - 2,000,000 2,000,000

Balance at Disposed/ Received as Balance at Vested and

beginning of Expired/ part of 2018 end of exercisable at

year Acquired Exercised/ remuneration Consolidation* year end of year

2018

David King 4,000,000 - - - (3,800,000) 200,000 200,000

Maria Halasz - - - - - - -

Bruce Gordon 2,000,000 - - - (1,900,000) 100,000 100,000

Fintan Walton 2,000,000 - - - (1,900,000) 100,000 100,000

Martin Cross - - - - - - -

Dennis Eck - - - - - - -